IR BioSciences (CE) Aktie - IRBS

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Premium

Current Price

0,000001

Gebot

0,00

Fragen

0,00

Volumen

0,00 Tagesbereich 0,00

0,000001 52-Wochen-Bereich 0,0001

Handelsende

0,000001

Handelsbeginn

Letzte Trade

Letzter Handelszeitpunkt

Durchschnittliches Volumen (3 Mio.)

Finanzvolumen

VWAP

ImmuneRegen BioSciences(R) Reports Positive Results in Cancer Vaccine Studies in Radboud University Collaboration

SCOTTSDALE, Ariz., Oct. 28, 2010 (GLOBE NEWSWIRE) -- ImmuneRegen BioSciences, Inc.®, a wholly owned subsidiary of IR BioSciences Holdings, Inc...

ImmuneRegen BioSciences(R) Reports Scancell Collaboration Yielding Positive Results in Cancer Vaccine Studies of Homspera(R)

SCOTTSDALE, Ariz., Sept. 8, 2010 (GLOBE NEWSWIRE) -- ImmuneRegen BioSciences, Inc.®, a wholly owned subsidiary of IR BioSciences Holdings, Inc...

ImmuneRegen BioSciences(R) Invited to Submit Full Proposal to BARDA for Homspera(R) as a Potential Medical Countermeasure for In

SCOTTSDALE, Ariz., Aug. 31, 2010 (GLOBE NEWSWIRE) -- ImmuneRegen BioSciences®, a wholly owned subsidiary of IR Biosciences Holdings Inc...

University of Rochester Medical Center Receives $15 Million in Government Funding to Research ImmuneRegen's Homspera(R)

SCOTTSDALE, Ariz., Aug. 25, 2010 (GLOBE NEWSWIRE) -- ImmuneRegen BioSciences®, a wholly owned subsidiary of IR Biosciences Holdings Inc...

NeoStem, Inc. and ImmuneRegen BioSciences(R) Announce a Collaborative Agreement to Advance Stem Cell Technology

NeoStem, Inc. and ImmuneRegen BioSciences(R) Announce a Collaborative Agreement to Advance Stem Cell Technology PR Newswire NEW YORK and...

ImmuneRegen BioSciences Confirms Homspera's Therapeutic Anti-Influenza Effect on Pandemic H1N1 Influenza Virus After Oral Admini

Preliminary reports of oral bioavailability as well as therapeutic effects in ferret model of current H1N1 pandemic flu. SCOTTSDALE, Ariz., July...

WaferGen Biosystems, ImmuneRegen BioSciences and University of Texas Southwestern Medical Center to Collaborate on Novel Wound H

Studies at UT Southwestern to Leverage WaferGen's SmartChip Platform to Evaluate Efficacy of ImmuneRegen's Drug FREMONT, Calif. and SCOTTSDALE...

ImmuneRegen(R) BioSciences Confirms Homspera(R) Advances Wound Healing in Topical Application

ImmuneRegen? BioSciences, Inc., a wholly owned subsidiary of IR BioSciences Holdings, Inc. (OTCBB: IRBS), today announced that...

IR BioSciences Holdings, Inc. Closes New $5 Million Funding Round

IR BioSciences Holdings, Inc., a development-stage biotechnology company focused on the research, development and licensing of...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	1.0E-6	1.0E-6	1.0E-6	0	0	CS
52	0	0	1.0E-6	0.0001	1.0E-6	306	7.06E-6	CS
156	0	0	1.0E-6	0.0001	1.0E-6	7548	1.36E-6	CS
260	-9.9E-5	-99	0.0001	0.09	1.0E-6	58607	0.00022282	CS

IRBS - Frequently Asked Questions (FAQ)

What is the current IR BioSciences (CE) share price?

The current share price of IR BioSciences (CE) is US$ 0,000001

What is the 1 year trading range for IR BioSciences (CE) share price?

IR BioSciences (CE) has traded in the range of US$ 0,000001 to US$ 0,0001 during the past year

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
GSIHGeneral Steel Holdings Inc (CE)	US$ 0,10 (99.900,00%)	25,32k
AFIIQArmstrong Flooring Inc (CE)	US$ 0,0002 (19.900,00%)	300
IVRNInnoveren Scientific Inc (CE)	US$ 0,0002 (19.900,00%)	10k
GRLFGreen Leaf Innovations Inc (PK)	US$ 0,0001 (9.900,00%)	52,14M
FBCDFBC Holding Inc (PK)	US$ 0,0001 (9.900,00%)	23k
TBLTToughBuilt Industries Inc (CE)	US$ 0,000001 (-100,00%)	487
GNRSQGreenrose Holding Company Inc (CE)	US$ 0,000001 (-100,00%)	261
ELOXEloxx Pharmaceuticals Inc (CE)	US$ 0,0001 (-99,99%)	2,53k
TIGXFTeam Internet Group PLC (QX)	US$ 0,0001 (-99,99%)	100
BLIBQBB Liquidating Inc (CE)	US$ 0,000001 (-99,90%)	25k
GTVHGolden Triangle Ventures Inc (PK)	US$ 0,00035 (40,00%)	258,92M
HMBLHUMBL Inc (PK)	US$ 0,0005 (0,00%)	221,36M
GRPSGold River Productions Inc (PK)	US$ 0,0002 (-20,00%)	205,71M
TSOITherapeutic Solutions International Inc (PK)	US$ 0,0002 (-33,33%)	201,87M
AITXArtificial Intelligence Technology Solutions Inc (PK)	US$ 0,0025 (-3,85%)	187,8M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

IR BioSciences Holdings Inc New (CE) (IRBS)

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

IRBS Neueste Nachrichten

ImmuneRegen BioSciences(R) Reports Positive Results in Cancer Vaccine Studies in Radboud University Collaboration

ImmuneRegen BioSciences(R) Reports Scancell Collaboration Yielding Positive Results in Cancer Vaccine Studies of Homspera(R)

ImmuneRegen BioSciences(R) Invited to Submit Full Proposal to BARDA for Homspera(R) as a Potential Medical Countermeasure for In

University of Rochester Medical Center Receives $15 Million in Government Funding to Research ImmuneRegen's Homspera(R)

NeoStem, Inc. and ImmuneRegen BioSciences(R) Announce a Collaborative Agreement to Advance Stem Cell Technology

ImmuneRegen BioSciences Confirms Homspera's Therapeutic Anti-Influenza Effect on Pandemic H1N1 Influenza Virus After Oral Admini

WaferGen Biosystems, ImmuneRegen BioSciences and University of Texas Southwestern Medical Center to Collaborate on Novel Wound H

ImmuneRegen(R) BioSciences Confirms Homspera(R) Advances Wound Healing in Topical Application

IR BioSciences Holdings, Inc. Closes New $5 Million Funding Round

IRBS - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

IR BioSciences Holdings Inc New (CE) (IRBS) Börsenkurse

IR BioSciences Holdings Inc New (CE) (IRBS)

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

IRBS Neueste Nachrichten

ImmuneRegen BioSciences(R) Reports Positive Results in Cancer Vaccine Studies in Radboud University Collaboration

ImmuneRegen BioSciences(R) Reports Scancell Collaboration Yielding Positive Results in Cancer Vaccine Studies of Homspera(R)

ImmuneRegen BioSciences(R) Invited to Submit Full Proposal to BARDA for Homspera(R) as a Potential Medical Countermeasure for In

University of Rochester Medical Center Receives $15 Million in Government Funding to Research ImmuneRegen's Homspera(R)

NeoStem, Inc. and ImmuneRegen BioSciences(R) Announce a Collaborative Agreement to Advance Stem Cell Technology

ImmuneRegen BioSciences Confirms Homspera's Therapeutic Anti-Influenza Effect on Pandemic H1N1 Influenza Virus After Oral Admini

WaferGen Biosystems, ImmuneRegen BioSciences and University of Texas Southwestern Medical Center to Collaborate on Novel Wound H

ImmuneRegen(R) BioSciences Confirms Homspera(R) Advances Wound Healing in Topical Application

IR BioSciences Holdings, Inc. Closes New $5 Million Funding Round

IRBS - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Werbung entfernen